Assessing bolus retention in achalasia using high-resolution manometry with impedance: a comparator study with timed barium esophagram.
Yu K Cho, Anna M Lipowska, Frédéric Nicodème...
https://pubmed.ncbi.nlm.nih.gov/24710506Actively Recruiting
Led by Northwestern University · Updated on 2025-08-11
575
Participants Needed
1
Research Sites
N/A
Total Duration
N
Northwestern University
Lead Sponsor
T
The California Medical Innovations Institute, Inc.
Collaborating Sponsor
Researchers are studying swallowing difficulties, including functional dysphagia, ineffective esophageal motility (IEM), esophagogastric junction outflow obstruction (EGJOO), and achalasia. The trial aims to improve understanding of esophageal wall biomechanics and neuromyogenic function, which are important for normal swallowing but have been underexplored. This research builds on prior work that developed the Chicago Classification to diagnose esophageal motor disorders and seeks to identify new biomechanical markers for better diagnosis and treatment. The study uses advanced diagnostic tests like functional lumen impedance planimetry (FLIP), high-resolution manometry (HRM), and fluoroscopy-based techniques to measure esophageal wall mechanics, pressure, and diameter changes. Participants receive standard care and may undergo treatments such as prucalopride medication or botulinum toxin injections depending on their condition. The research includes assessments before and after interventions like peroral endoscopic myotomy (POEM) and fundoplication surgery to evaluate treatment effects. Participants aged 18 to 85 with swallowing issues or related esophageal conditions will complete questionnaires, imaging, endoscopy, and physiological tests at baseline and follow-up visits up to six months. Researchers will measure outcomes such as esophageal clearance, esophagogastric junction diameter and distensibility, reflux symptoms, and esophageal elasticity. These evaluations will help refine diagnostic models and treatment approaches for esophageal motility disorders.
CONDITIONS
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline assessments prior to treatment
Participants undergo standard of care diagnostic testing including endoscopy with FLIP, high resolution manometry (HRM), pH-impedance testing, and questionnaires to assess esophageal function and symptoms.
1 to 2 visits depending on procedures required
Duration - 2 weeks for medication or as per clinical treatment schedule for POEM
Participants with specific esophageal conditions receive targeted treatments such as a 2-week course of prucalopride medication or undergo peroral endoscopic myotomy (POEM) as part of their clinical care.
1 to 2 treatment visits plus medication daily as prescribed
Duration - Up to 6 months after treatment
After treatment, participants undergo follow-up diagnostic procedures including FLIP, HRM, esophagram evaluation, and questionnaires to assess treatment effects.
1 to 2 visits up to 6 months post-treatment
Duration - Up to 6 months post-treatment
Participants are monitored over time to assess long-term outcomes such as esophageal clearance, symptom improvement, and treatment success.
Follow-up visits over 6 months
Total: 1 location
1
Northwestern University
Chicago, Illinois, United States, 60611
Actively Recruiting
J
John E Pandolfino, MD
D
Dustin A Carlson, MD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Yu K Cho, Anna M Lipowska, Frédéric Nicodème...
https://pubmed.ncbi.nlm.nih.gov/24710506M Halland, K Ravi, J Barlow...
https://pubmed.ncbi.nlm.nih.gov/25327483Alyse Bedell, Tiffany H Taft, Laurie Keefer...
https://pubmed.ncbi.nlm.nih.gov/26881974Matthew C Cieslak, Ann M Castelfranco, Vittoria Roncalli...
https://pubmed.ncbi.nlm.nih.gov/31784353Shashank Acharya, Wenjun Kou, Sourav Halder...
https://pubmed.ncbi.nlm.nih.gov/33625493Shashank Acharya, Sourav Halder, Dustin A Carlson...
https://pubmed.ncbi.nlm.nih.gov/33174457Sourav Halder, Shashank Acharya, Wenjun Kou...
https://pubmed.ncbi.nlm.nih.gov/33651206A C Barnard, W A Hunt, W P Timlake...
https://pubmed.ncbi.nlm.nih.gov/5972373Amy L Holmstrom, Ryan A J Campagna, Arturo Cirera...
https://pubmed.ncbi.nlm.nih.gov/32632483Ezra N Teitelbaum, Nathaniel J Soper, John E Pandolfino...
https://pubmed.ncbi.nlm.nih.gov/25055891